Updated clinical guidance issued for suspected e-cigarette or vaping product use-associated lung injury

A guidance document provides updated clinical recommendations for health care professionals evaluating and managing patients with suspected e-cigarette, or vaping, product use-associated lung injury. The document does not specify a study design, sample size, or follow-up duration. No intervention, comparator, or primary or secondary outcomes are reported.

No main results, safety data, or tolerability information are provided in the available evidence. Adverse events, serious adverse events, and discontinuations are not reported. The guidance is presented without supporting efficacy or safety metrics from a specific clinical investigation.

Key limitations include the absence of reported study methodology, population characteristics, and comparative effectiveness data. The funding source and potential conflicts of interest are not reported. The practice relevance is framed as providing updated clinical guidance, but clinicians should note the lack of underlying evidentiary details typically associated with treatment guidelines.